Firstly, as of today (2019-07-15) we’ve determined the following resources to be extremely useful for Corvus Pharmaceuticals, Inc. investors – we recommend taking a look. Take your time with the following:
Beat The Market Analyzer: https://logistics-business-review.com/recommended-tool-for-CRVS-investors (this is a fantastic tool – use this to analyze Corvus Pharmaceuticals, Inc. in much more depth)
MM Publishing: https://logistics-business-review.com/mmpublishing-for-CRVS-investors
Trading Code: https://logistics-business-review.com/tradingcode-for-CRVS-investors
Trader HR: https://logistics-business-review.com/traderHR-for-CRVS-investors
REPORTING FOR 2019-07-15 | LOGISTICS-BUSINESS-REVIEW.COM: We have conducted a deep analysis of how Corvus Pharmaceuticals, Inc. ($CRVS) has been trading over the last 2 weeks and the past day especially. On its latest session, Corvus Pharmaceuticals, Inc. ($CRVS) opened at 5.53, reaching a high of 5.64 and a low of 5.4 before closing at a price of 5.61. There was a total volume of 144772.
VOLUME INDICATORS: We saw an accumulation-distribution index of 40.105, an on-balance volume of -5.48, chaikin money flow of 3.36364 and a force index of 0.0025. There was an ease of movement rating of -0.00161, a volume-price trend of 1.93694 and a negative volume index of 1000.0.
VOLATILITY: We noted an average true range of 0.1902, bolinger bands of 5.46399, an upper bollinger band of 5.26601, lower bollinger band of 5.4, a bollinger high band indicator of 1.0, bollinger low band indicator of 1.0, a central keltner channel of 5.52333, high band keltner channel of 5.41333, low band keltner channel of 5.63333, a high band keltner channel indicator of 1.0 and a low band keltner channel indicator of 1.0. There was a donchian channel high band of 5.4, a donchian channel low band of 5.4, a donchian channel high band indicator of 1.0, and a donchian channel low band indicator of 1.0.
TREND: We calculated a Moving Average Convergence Divergence (MACD) of -0.00157, a MACD signal of -0.00087, a MACD difference of -0.0007, a fast Exponential Moving Average (EMA) indicator of 5.4, a slow Exponential Moving Average (EMA) indicator of 5.4, an Average Directional Movement Index (ADX) of unknown, an ADX positive of 20.0, an ADX negative of 20.0, a positive Vortex Indicator (VI) of 1.0, a negative VI of 1.0, a trend vortex difference of 1.22718, a trix of 27.87386, a Mass Index (MI) of 1.0, a Commodity Channel Index (CCI) of 66.66667, a Detrended Price Oscillator (DPO) of -1.38036, a KST Oscillator (KST) of 343.40322 and a KST Oscillator (KST Signal) of 343.40322 (leaving a KST difference of -4.35362). We also found an Ichimoku rating of 5.585, an Ichimoku B rating of 5.585, a Ichimoku visual trend A of 4.42231, an Ichimoku visual trend B of 4.68757, an Aroon Indicator (AI) up of 4.0 and an AI indicator down of 4.0. That left a difference of -4.0.
MOMENTUM: We found a Relative Strength Index (RSI) of 50.0, a Money Flow Index (MFI) of 100.0, a True Strength Index (TSI) of 100.0, an ultimate oscillator of 91.39277, a stochastic oscillator of 218.18182, a stochastic oscillator signal of 218.18182, a Williams %R rating of 118.18182 and an awesome oscillator of 0.10347.
RETURNS: There was a daily return of 34.34032, a daily log return of -1.30477 and a cumulative return of -1.2963.
What the heck does all of this mean? If you are new to technical analysis, the above may be gibberish to you, and that’s OK (though we do advise learning these things). The bottom line is that AS OF 2019-07-15 (if you are reading this later, the analysis will be out of date), here is what our deep analysis of technical indicators are telling us for Corvus Pharmaceuticals, Inc. ($CRVS)…
For a more complete analysis, run all of this through the BTMA software. Also, to stay up to date with what is happening on Corvus Pharmaceuticals, Inc., we strongly advise Corvus Pharmaceuticals, Inc. investors to subscribe to MarketBeat.com’s daily email newsletter for updates, news and analyst ratings on stocks like Corvus Pharmaceuticals, Inc. – without this you are trading blind:
We will of course continue to cover the news and price action of Corvus Pharmaceuticals, Inc., but it’s easiest for you to just subscribe to MarketBeat’s newsletter above so you don’t miss anything.
DISCLAIMER: We are not registered investment advisers and the above analysis should be taken at face value only. We strongly advise against buying or selling Corvus Pharmaceuticals, Inc. ($CRVS) based solely on our analysis above, and are not responsible for any losses that you may incur if you choose make any investment decisions based on the above.
Latest posts by Gary Ivenchuck (see all)
- The Battle Of Kamada Ltd. ($KMDA) And Midatech Pharma PLC ($MTP) - August 20, 2019
- What’s Better: Quidel Corporation ($QDEL) or Oxford Immunotec Global PLC ($OXFD) - August 20, 2019
- Allakos Inc. ($ALLK) Heads Up Against Sarepta Therapeutics, Inc. ($SRPT) - August 20, 2019